In a scopolamine-induced AD mice model, curcumin reduced the formation of Aβ aggregates by downregulating glycogen synthase kinase (GSK3β) enzyme activity, an enzyme known to regulate BACE1 activity [93]. The gene discussed is BACE1; the disease is Alzheimer disease.